Ilyang Pharmaceutical has found the treatment substance of the “MERS virus”
The Ilyang Pharmaceutical’s(President Dong-yeon Kim) ‘candidate substance of the MERS virus treatment’ has been proved in effectiveness by the Korean Society of Virology(President: Yong-soo Bae).
According to the company, it requested a verification for the candidate substance as finding out tha...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
